Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J3VX
|
||||
Former ID |
DNC007545
|
||||
Drug Name |
1-(isoquinolin-5-yl)-3-(4-morpholinobenzyl)urea
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528909] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H22N4O2
|
||||
Canonical SMILES |
C1COCCN1C2=CC=C(C=C2)CNC(=O)NC3=CC=CC4=C3C=CN=C4
|
||||
InChI |
1S/C21H22N4O2/c26-21(24-20-3-1-2-17-15-22-9-8-19(17)20)23-14-16-4-6-18(7-5-16)25-10-12-27-13-11-25/h1-9,15H,10-14H2,(H2,23,24,26)
|
||||
InChIKey |
LAJBRLBYOVKUOY-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [528909] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.